Efficient induction of cytotoxic T lymphocytes specific to hepatocellular carcinoma using HLA-A2-restricted MAGE-n peptide in vitro

Cancer Letters
Hai-long DongShao-ying Lu

Abstract

MAGE-n is a new member of MAGE gene family and has been demonstrated closely associated with hepatocellular carcinoma (HCC). In this study, MAGE-n-derived peptide-specific cytotoxic T lymphocytes (CTL) were induced from the peripheral blood mononuclear cells of healthy donors by multiple stimulations with HLA-A2-restricted MAGE-n peptide-pulsed T2 cells. The induced CTLs exhibited specific lysis against T2 cells pulsed with the peptide and HLA-A2+ HCC cells expressing MAGE-n, while HLA-A2+ HCC cell lines that did not express MAGE-n could not be recognized by the CTLs. The peptide-specific activity was inhibited by anti-MHC class I monoclonal antibody. These results suggested the MAGE-n peptide could be a potential target of specific immunotherapy for HLA-A2 patients with HCC.

References

Dec 22, 1999·Immunogenetics·H RammenseeS Stevanović
Apr 24, 2001·Cancer Immunology, Immunotherapy : CII·N RenkvistG Parmiani
Nov 15, 2001·International Journal of Clinical Oncology·R EifukuK Yasumoto
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·M H AndersenE Kämpgen
Feb 19, 2002·Expert Opinion on Biological Therapy·Lisa H Butterfield, Antoni Ribas
Aug 8, 2002·Journal of Gastroenterology and Hepatology·Andrew LadhamsGraham Cooksley

❮ Previous
Next ❯

Citations

Jan 6, 2005·World Journal of Gastroenterology : WJG·Hai-Long Dong, Yan-Fang Sui
Mar 8, 2008·Expert Opinion on Drug Safety·Antoine Thiery-VuilleminXavier Pivot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.